Megha Manchanda &Amp;Amp; Sohini Das

Stories by Megha Manchanda &Amp;Amp; Sohini Das

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com   18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

Rediff.com   11 Aug 2021

India is not keen to 'bow down' to demands related to indemnity against legal liabilities in case any vaccine recipient develops severe adverse reactions post inoculation.

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Rediff.com   6 Aug 2021

While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.

AstraZeneca finds small clot risk after 1st Covid shot

AstraZeneca finds small clot risk after 1st Covid shot

Rediff.com   29 Jul 2021

But no extra risk after second dose, shows study led and funded by drug maker, reports Sohini Das.

Russia reaches out to Kerala for Sputnik V plant

Russia reaches out to Kerala for Sputnik V plant

Rediff.com   29 Jul 2021

The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms outside that country. Shine Jacob and Sohini Das report.

3rd wave: Govt creating 30-day stock of key Covid medicines

3rd wave: Govt creating 30-day stock of key Covid medicines

Rediff.com   26 Jul 2021

'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What's better is that this time, the government is paying us in advance,' said a senior executive of a Mumbai-based pharma player which makes Remdesivir. Sohini Das reports.

Cash-strapped Vodafone Idea gets nod for FDI up to Rs 15,000 crore

Cash-strapped Vodafone Idea gets nod for FDI up to Rs 15,000 crore

Rediff.com   23 Jul 2021

Cash-strapped telco Vodafone Idea's proposal for investment of up to Rs 15,000 crore through foreign direct investment (FDI) has been approved by the Union government, according to officials. A top-level group, comprising representatives from the ministries of home affairs, external affairs, finance and commerce and industry, took the decision. The nod, which is an enabling provision, would help the financially-stressed company raise funds to pay up some of its dues linked to adjusted gross revenue (AGR), reduce debts and use the money for operational expenses.

Airtel hikes tariffs, family postpaid plan spiked for new customers

Airtel hikes tariffs, family postpaid plan spiked for new customers

Rediff.com   23 Jul 2021

Bharti Airtel on Thursday announced new postpaid plans and discontinued some previous ones. "In the post-pandemic world, an abundance of high-speed data is increasingly becoming a key need for customers as work from home and online education is the new normal. "In this context, Airtel has further simplified its postpaid plans to offer industry-leading data benefits backed by a 5G-ready network and superior digital-first customer care. "The plans also come with a range of exclusive benefits such as bundled content and business productivity tools," Airtel said in a press release.

Navy's reluctance to vacate spectrum may delay 5G auction

Navy's reluctance to vacate spectrum may delay 5G auction

Rediff.com   21 Jul 2021

The Indian Navy has expressed reservations in vacating 100 Mhz of the spectrum, proposed to be sold in the tender expected next year, sources said. This could delay the Centre's plans to proceed with the 5G auctions in 2022. A department of telecom (DoT) official said, "The Indian Navy is showing reluctance in vacating the spectrum from the 3.3 GHz-3.4 GHz band that it is using. "Unless there is some traction with them on this issue, we can't seek consultation from TRAI." The 3300 MHz-3600 MHz (or 3.3GHz-3.6GHz) will be auctioned for the first time in the proposed 5G auctions, likely next year.

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Rediff.com   19 Jul 2021

So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Rediff.com   14 Jul 2021

The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products.

Serum to double Covid vaccine output in 2022

Serum to double Covid vaccine output in 2022

Rediff.com   13 Jul 2021

SII would be scaling up its AstraZeneca-Oxford vaccine manufacturing capacity to 200 million doses a month from 100 million a month now, reports Sohini Das.

Explained: What the Brazil-Covaxin row is about

Explained: What the Brazil-Covaxin row is about

Rediff.com   9 Jul 2021

Three entities are at the centre of this controversy: The Brazilian government, Bharat Biotech and a Singapore-based company called Madison Biotech.

India may get 4m doses of Pfizer, Moderna by August from COVAX

India may get 4m doses of Pfizer, Moderna by August from COVAX

Rediff.com   8 Jul 2021

However, before the Moderna and Pfizer messenger ribonucleic acid (or mRNA) vaccines come to India via this route, the legalities around the indemnity clause will have to be settled, reports Sohini Das.

Fear and myths injecting Covid vaccine hesitancy

Fear and myths injecting Covid vaccine hesitancy

Rediff.com   6 Jul 2021

A June 11 survey by cLocalCircles across 299 districts puts overall vaccine hesitancy levels at 18 per cent, with 11 per cent of the respondents saying they were not convinced if the currently available vaccines would protect them against the new strains; and 5 per cent said they do not plan to take the vaccine at all.

Why Thyrocare sold out to PharmEasy

Why Thyrocare sold out to PharmEasy

Rediff.com   5 Jul 2021

'I have done enough work for many years.' 'This is a decision that many people at my age need to review.' 'I may become an exit example for people to study.'

Road construction zooms nearly 60% in 1st two months of FY22

Road construction zooms nearly 60% in 1st two months of FY22

Rediff.com   3 Jul 2021

Road construction witnessed a near 60 per cent year-on-year jump in the first two months of financial year 2021-22 (FY22), despite restrictions being imposed in the wake of the second wave of Covid-19. Around 1,470 km of roads were constructed during the first two months of the current fiscal, as against 847 km in the corresponding period last year, according to official figures. However, these are provisional numbers as the state public works departments of Maharashtra and Goa are yet to provide data.

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Rediff.com   2 Jul 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.

'Covid vaccines are working against new variants'

'Covid vaccines are working against new variants'

Rediff.com   2 Jul 2021

'The key purpose of vaccination is to prevent hospitalisation, severe disease, and death.' 'All vaccines work equally, although mild disease cannot be prevented.'

Serum applies for EU Covishield nod through AstraZeneca

Serum applies for EU Covishield nod through AstraZeneca

Rediff.com   30 Jun 2021

We have applied for marketing authorisation to the EMA through AstraZeneca. We will not sell the vaccine in the EU, said a company source.